BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23643086)

  • 1. [Identification of the epitope of von Willebrand factor recognized by monoclonal antibody SZ-125 with immune-affinity mass spectrometry].
    Li X; Wang F; Shen F; Zhao Y; Jiang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):284-6. PubMed ID: 23643086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of human VWF A3 recognized by monoclonal antibody SZ-123 and SZ-125 using MALDI mass spectrometry.
    Jiang M; Zhao Y; Shen F; Wang F; He Y; Ruan C
    Int J Hematol; 2011 Sep; 94(3):241-247. PubMed ID: 21822587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry.
    Papac DI; Hoyes J; Tomer KB
    Protein Sci; 1994 Sep; 3(9):1485-92. PubMed ID: 7530543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization and functional studies of vWF A3 domain monoclonal antibodies that inhibit binding of vWF to collagen].
    Zhao YM; Dong NZ; Shen F; Xie LQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):171-4. PubMed ID: 18788616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor.
    Kemptner J; Marchetti-Deschmann M; Müller R; Ivens A; Turecek P; Schwarz HP; Allmaier G
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):761-7. PubMed ID: 20169558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G; Ribba AS; Chérel G; Siguret V; Obert B; Rouault C; Ginsburg D; Meyer D
    Thromb Haemost; 1994 Jun; 71(6):788-92. PubMed ID: 7974349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping by mass spectrometry: determination of an epitope on HIV-1 IIIB p26 recognized by a monoclonal antibody.
    Parker CE; Papac DI; Trojak SK; Tomer KB
    J Immunol; 1996 Jul; 157(1):198-206. PubMed ID: 8683115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
    South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
    Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping epitopes of monoclonal antibodies against HIV-1 integrase with limited proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Yi J; Skalka AM
    Biopolymers; 2000; 55(4):308-18. PubMed ID: 11169922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction.
    Vanhoorelbeke K; Depraetere H; Romijn RA; Huizinga EG; De Maeyer M; Deckmyn H
    J Biol Chem; 2003 Sep; 278(39):37815-21. PubMed ID: 12855711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12.
    Ansong C; Miles SM; Fay PJ
    J Thromb Haemost; 2006 Apr; 4(4):842-7. PubMed ID: 16634755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
    Hochleitner EO; Borchers C; Parker C; Bienstock RJ; Tomer KB
    Protein Sci; 2000 Mar; 9(3):487-96. PubMed ID: 10752610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of antibodies by mass spectroscopy: a case study.
    Obungu VH; Gelfanova V; Huang L
    Methods Mol Biol; 2013; 988():291-302. PubMed ID: 23475727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
    Macht M; Fiedler W; Kürzinger K; Przybylski M
    Biochemistry; 1996 Dec; 35(49):15633-9. PubMed ID: 8961925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
    Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis.
    Xiong Y; Bernardi D; Bratton S; Ward MD; Battaglia E; Finel M; Drake RR; Radominska-Pandya A
    Biochemistry; 2006 Feb; 45(7):2322-32. PubMed ID: 16475821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational and sequential epitopes on the human granulocyte-colony stimulating factor molecule (hG-CSF) and their role in binding to human placenta receptors.
    Marino VJ; Sterin-Prync AE; Carbonetto CH; Roguin LP
    Cytokine; 2001 Oct; 16(2):41-50. PubMed ID: 11683584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS; Loisel I; Lavergne JM; Juhan-Vague I; Obert B; Cherel G; Meyer D; Girma JP
    Thromb Haemost; 2001 Sep; 86(3):848-54. PubMed ID: 11583318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13.
    Zhang L; Su J; Shen F; Ma Z; Zhao Y; Xia L; Ruan C
    J Hematol Oncol; 2017 Feb; 10(1):42. PubMed ID: 28166803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.